Clinical trial
A Phase II Study of Hu1D10 in Recurrent Hodgkin's Disease
NCT00055783 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Hu1D10 in Recurrent Hodgkin's Disease
- Lead sponsor
- Stanford University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2002
- Completion date
- April 30, 2003
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.